AR036462A1 - Un compuesto esteroidal y su uso para la fabricacion de un medicamento - Google Patents
Un compuesto esteroidal y su uso para la fabricacion de un medicamentoInfo
- Publication number
- AR036462A1 AR036462A1 ARP020103415A ARP020103415A AR036462A1 AR 036462 A1 AR036462 A1 AR 036462A1 AR P020103415 A ARP020103415 A AR P020103415A AR P020103415 A ARP020103415 A AR P020103415A AR 036462 A1 AR036462 A1 AR 036462A1
- Authority
- AR
- Argentina
- Prior art keywords
- manufacture
- steroidal compound
- medicinal product
- compound
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un compuesto esteroidal, que tiene la fórmula (1), donde: R1 es O, (H, H), (H, OH), NOH, donde OH está opcionalmente eterificado o esterificado; R2 y R3 son independientemente hidrógeno o alquilo C1-4, y al menos uno de R2 y R3 es alquilo C1-4; y R4 es hidrógeno o acilo C1-15. El uso del compuesto esteroidal para la fabricación de un medicamento para el uso en un tratamiento relacionado con andrógenos. El compuesto de fórmula (1) es útil por ejemplo para el tratamiento de la insuficiencia androgénica y en anticoncepción masculina o femenina.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01203455 | 2001-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR036462A1 true AR036462A1 (es) | 2004-09-08 |
Family
ID=8180920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103415A AR036462A1 (es) | 2001-09-12 | 2002-09-10 | Un compuesto esteroidal y su uso para la fabricacion de un medicamento |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7169769B2 (es) |
| EP (1) | EP1427748B1 (es) |
| JP (1) | JP4471653B2 (es) |
| KR (1) | KR100940054B1 (es) |
| CN (1) | CN1257913C (es) |
| AR (1) | AR036462A1 (es) |
| AT (1) | ATE395352T1 (es) |
| AU (1) | AU2002339536B2 (es) |
| BR (1) | BR0212409A (es) |
| CA (1) | CA2505575C (es) |
| CY (1) | CY1108152T1 (es) |
| DE (1) | DE60226623D1 (es) |
| DK (1) | DK1427748T3 (es) |
| EC (1) | ECSP045012A (es) |
| ES (1) | ES2305306T3 (es) |
| HK (1) | HK1063637A1 (es) |
| HR (1) | HRP20040193A2 (es) |
| HU (1) | HUP0402139A3 (es) |
| IL (2) | IL160451A0 (es) |
| IS (1) | IS2555B (es) |
| MX (1) | MXPA04002418A (es) |
| NO (1) | NO326624B1 (es) |
| NZ (1) | NZ531487A (es) |
| PL (1) | PL207493B1 (es) |
| PT (1) | PT1427748E (es) |
| RU (1) | RU2294332C2 (es) |
| TW (1) | TWI221154B (es) |
| WO (1) | WO2003022864A1 (es) |
| ZA (1) | ZA200401992B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3338925A (en) * | 1965-10-25 | 1967-08-29 | Syntex Corp | 17-substituted 14beta-estr-4-enes |
| AU3162200A (en) | 1999-03-08 | 2000-09-28 | Akzo Nobel N.V. | 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
| AU4299301A (en) * | 2000-02-29 | 2001-09-12 | National University Of Singapore, The | A method for modulating steroidogenic activity |
| US6391868B2 (en) * | 2000-05-10 | 2002-05-21 | Lpt Research, Inc. | Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans |
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
-
2002
- 2002-07-19 TW TW091116164A patent/TWI221154B/zh not_active IP Right Cessation
- 2002-09-06 US US10/489,456 patent/US7169769B2/en not_active Expired - Lifetime
- 2002-09-06 AT AT02777036T patent/ATE395352T1/de active
- 2002-09-06 KR KR1020047003609A patent/KR100940054B1/ko not_active IP Right Cessation
- 2002-09-06 HU HU0402139A patent/HUP0402139A3/hu unknown
- 2002-09-06 CN CNB02817853XA patent/CN1257913C/zh not_active Expired - Lifetime
- 2002-09-06 DK DK02777036T patent/DK1427748T3/da active
- 2002-09-06 NZ NZ531487A patent/NZ531487A/en not_active IP Right Cessation
- 2002-09-06 PL PL368727A patent/PL207493B1/pl not_active IP Right Cessation
- 2002-09-06 DE DE60226623T patent/DE60226623D1/de not_active Expired - Lifetime
- 2002-09-06 RU RU2004110934/04A patent/RU2294332C2/ru not_active IP Right Cessation
- 2002-09-06 IL IL16045102A patent/IL160451A0/xx unknown
- 2002-09-06 WO PCT/EP2002/010041 patent/WO2003022864A1/en active IP Right Grant
- 2002-09-06 CA CA2505575A patent/CA2505575C/en not_active Expired - Lifetime
- 2002-09-06 AU AU2002339536A patent/AU2002339536B2/en not_active Expired
- 2002-09-06 BR BR0212409-2A patent/BR0212409A/pt not_active IP Right Cessation
- 2002-09-06 PT PT02777036T patent/PT1427748E/pt unknown
- 2002-09-06 ES ES02777036T patent/ES2305306T3/es not_active Expired - Lifetime
- 2002-09-06 EP EP02777036A patent/EP1427748B1/en not_active Expired - Lifetime
- 2002-09-06 JP JP2003526937A patent/JP4471653B2/ja not_active Expired - Fee Related
- 2002-09-06 MX MXPA04002418A patent/MXPA04002418A/es active IP Right Grant
- 2002-09-10 AR ARP020103415A patent/AR036462A1/es unknown
-
2004
- 2004-02-18 IL IL160451A patent/IL160451A/en not_active IP Right Cessation
- 2004-02-26 HR HR20040193A patent/HRP20040193A2/hr not_active Application Discontinuation
- 2004-02-26 IS IS7165A patent/IS2555B/is unknown
- 2004-03-10 EC EC2004005012A patent/ECSP045012A/es unknown
- 2004-03-10 NO NO20041010A patent/NO326624B1/no not_active IP Right Cessation
- 2004-03-11 ZA ZA200401992A patent/ZA200401992B/en unknown
- 2004-08-24 HK HK04106336A patent/HK1063637A1/xx not_active IP Right Cessation
-
2008
- 2008-06-19 CY CY20081100653T patent/CY1108152T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2189768T3 (es) | Sintesis regioselectiva de derivados de rapamicina. | |
| BR0104654A (pt) | Artigo absorvente | |
| AP1422A (en) | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent. | |
| ES2114931T3 (es) | Nuevos esteres esteroidales. | |
| ECSP055629A (es) | COMPOSICIÓN QUE CONTIENE UN ESTEROIDE 11ß-HALOGENADO ANDRÓGENO Y UN GESTÁGENO ASÍ COMO UN CONTRACEPTIVO MASCULINO SOBRE LA BASE DE ESTAS COMPOSICIONES | |
| ECSP034542A (es) | Nuevos agentes anticolinergicos que se pueden emplear como medicamentos asi como procedimiento para su preparacion | |
| AR030707A1 (es) | 9-ALFA-CLORO-6-ALFA-FLUOR-17-ALFA-HIDROXI-16-METIL-17-BETA-METOXICARBONIL-ANDROST-1,4-DIENOS, UN PROCESO PARA SU PREPARACIoN , COMPOSICION FARMACEUTICA, Y EL USO DEL MISMO PARA LA FABRICACION DE MEDICAMENTO | |
| AR077416A2 (es) | Compuesto polimorfo estable de flibanserina , procedimiento industrial para su preparacion y uso del mismo para preparar medicamentos | |
| SI1534678T1 (sl) | Plevromutilinski derivati kot antimikrobna sredstva | |
| NO20032805L (no) | Blandinger med ostrogen-syklodekstrinkomplekser | |
| CY1108093T1 (el) | Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη | |
| BRPI0400214A (pt) | Composições e aplicações farmacêuticas para a obtenção confiável de nìveis aceitáveis de testosterona no soro | |
| CO5631449A2 (es) | Nuevos esteres de etonogestrel | |
| ATE285174T1 (de) | Neuartige verbindungen | |
| AR025052A1 (es) | Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos. | |
| CA2013599A1 (en) | Aryl-substituted rhodanine derivatives | |
| HK1045990A1 (en) | Novel derivatives and analogues of galanthamin. | |
| RS50229B (sr) | Analozi vitamina d3 | |
| AR036462A1 (es) | Un compuesto esteroidal y su uso para la fabricacion de un medicamento | |
| IT1318667B1 (it) | Medicamento antinfiammatorio. | |
| AR026655A1 (es) | Nuevos esteroides con actividad androgenica y su uso como antinconceptivos masculinos y para tratar la insuficiencia androgenica | |
| NZ505614A (en) | Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets | |
| NO20023276D0 (no) | Fremgangsmåte til å fremstille betulinsyre | |
| YU59403A (sh) | Androgeni 7-supstituisani 11-halogenovani steroidi | |
| NO20031444L (no) | 17<alfa>-fluoralkylsteroider, fremgangsmåte for fremstilling av disse, og farmasöytiske preparater som inneholder disse forbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |